| Baseline | 4 weeks |
---|
Placebo | MFGM | Placebo | MFGM |
---|
Body weight, kg | 69.0 ± 2.7 | 69.5 ± 2.8 | 69.0 ± 2.7 | 69.5 ± 2.7 |
Body fat ratio, % | 18.6 ± 1.6 | 17.7 ± 1.5 | 18.4 ± 1.6 | 18.3 ± 1.6 |
Whole BMM, kg | 52.8 ± 1.2 | 53.8 ± 1.4 | 52.9 ± 1.2 | 53.3 ± 1.2 |
Leg muscle mass, kg | 9.7 ± 0.36 | 9.9 ± 0.38 | 10.0 ± 0.34 | 10.0 ± 0.36 |
Thigh circumference, cm | 45.8 ± 0.9 | 46.2 ± 0.9 | 45.8 ± 0.8 | 45.9 ± 0.9 |
- MFGM Milk fat globule membrane, BMM Body muscle mass
- Body weight, body fat ratio, whole body and leg (average of left and right) muscle mass were measured using a bioimpedance body fat analyzer (BC-621, Tanita, Co., Tokyo, Japan). Thigh circumference (average of left and right) was measured 15 cm proximal to the superior pole of the patella
- Values are mean ± SEM (n = 14). There were no significant differences between the groups and the changes within each group from baseline